EN Perché l'Italia deve tornare a fare industria dell'innovazione biomedica
In questo numero
Cover story
EN Perché l'Italia deve tornare a fare industria dell'innovazione biomedica
di
Gianluca Polifrone
Highlights
What industry no longer does, tourism can – but only if it changes shape
by
Ruben Pescara
Highlights
The new relationship between companies and lawyers
by
Gianmatteo Nunziante
Key Legal Implications of Outsourcing Services
by
Alessia Consiglio
, Giuseppe Cucurachi
Ryanair and the €255 million abuse
by
Micol Rossi
For design-oriented businesses, the approach to protection is changing
by
Emanuela Gaia Zapparoli
Airlines and shipping companies in the crosshairs
by
Claudio Giordano